T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
SEI Investments
SEIC
$12.8B
| $2.11M | ﹤0.01% |
49,045
+9,388
| +24% | +$385K |
|
1502
AGNC Investment
AGNC
$13B
| $2.09M | ﹤0.01% |
112,006
+34,876
| +45% | +$619K |
|
|
ASNA
1503
DELISTED
Ascena Retail Group, Inc.
ASNA
| $2.07M | ﹤0.01% |
9,375
-6,262
| -40% | -$1.1M |
|
|
INFI
1504
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.07M | ﹤0.01% |
392,860
-220,860
| -36% | -$1.35M |
|
1505
W.P. Carey
WPC
$16.3B
| $2.06M | ﹤0.01% |
33,759
+5,105
| +18% | +$290K |
|
|
ATYR
1506
aTyr Pharma
ATYR
$54.2M
| $2.05M | ﹤0.01% |
37,175
-46,326
| -55% | -$3.52M |
|
|
SRC
1507
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $2.05M | ﹤0.01% |
40,565
+10,704
| +36% | +$500K |
|
1508
Lamar Advertising Co
LAMR
$15.8B
| $2.03M | ﹤0.01% |
33,008
+3,550
| +12% | +$203K |
|
|
CCRN
1509
DELISTED
Cross Country Healthcare
CCRN
| $2.03M | ﹤0.01% |
+174,390
| New | +$2.22M |
|
1510
CDW
CDW
$17.8B
| $2.03M | ﹤0.01% |
48,873
+16,200
| +50% | +$631K |
|
1511
PUT
JPMorgan Chase
JPM
$965B
| $2.03M | ﹤0.01% |
+350,000
| New | +$20.4M |
|
|
CPN
1512
DELISTED
Calpine Corporation
CPN
| $2.02M | ﹤0.01% |
133,256
+26,323
| +25% | +$369K |
|
1513
Hilltop Holdings
HTH
$2.28B
| $1.99M | ﹤0.01% |
105,198
-9,900
| -9% | -$167K |
|
1514
Canadian National Railway
CNI
$77.2B
| $1.98M | ﹤0.01% |
31,620
+600
| +2% | +$33.6K |
|
1515
Sonoco
SON
$5.77B
| $1.98M | ﹤0.01% |
40,803
+611
| +2% | +$26K |
|
|
HERO
1516
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $1.98M | ﹤0.01% |
825,961
| – | – |
|
1517
American Financial Group
AFG
$12.1B
| $1.98M | ﹤0.01% |
28,101
+5,800
| +26% | +$397K |
|
1518
Huntington Ingalls Industries
HII
$12.8B
| $1.97M | ﹤0.01% |
14,355
+763
| +6% | +$99.3K |
|
1519
Nabors Industries
NBR
$1.35B
| $1.96M | ﹤0.01% |
4,255
+1,242
| +41% | +$461K |
|
1520
Crown Holdings
CCK
$12.9B
| $1.94M | ﹤0.01% |
39,206
+8,203
| +26% | +$385K |
|
|
DERM
1521
DELISTED
Dermira, Inc.
DERM
| $1.94M | ﹤0.01% |
+93,970
| New | +$2.31M |
|
1522
Commercial Metals
CMC
$7.98B
| $1.94M | ﹤0.01% |
114,400
-7,500
| -6% | -$110K |
|
|
NUAN
1523
DELISTED
Nuance Communications, Inc.
NUAN
| $1.94M | ﹤0.01% |
119,767
-289,525
| -71% | -$4.68M |
|
|
LPT
1524
DELISTED
Liberty Property Trust
LPT
| $1.94M | ﹤0.01% |
57,853
+6,218
| +12% | +$187K |
|
|
SCTY
1525
DELISTED
SolarCity Corporation
SCTY
| $1.93M | ﹤0.01% |
78,536
+65,819
| +518% | +$1.88M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.